Lindbrook Capital’s Morphic Holding, Inc. Common Stock MORF Stock Holding History

Lindbrook Capital’s Portfolio MORF Stock Details MORF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-122	Closed	-$4.16K	–	2935
2024 Q2	$4.16K	Buy	122 +30	+33%	+$889	﹤0.01%	2085
2024 Q1	$3.24K	Hold	92	–	–	﹤0.01%	2072
2023 Q4	$2.66K	Buy	92 +78	+557%	+$1.86K	﹤0.01%	2164
2023 Q3	$321	Buy	14 +7	+100%	+$367	﹤0.01%	2597
2023 Q2	$401	Buy	+7	New	+$366	﹤0.01%	2552
2023 Q1	–	Sell	-11	Closed	-$294	–	2940
2022 Q4	$294	Sell	11 -13	-54%	-$355	﹤0.01%	2682
2022 Q3	$1K	Buy	24 +13	+118%	+$362	﹤0.01%	2554
2022 Q2	$0	Buy	+11	New	+$307	﹤0.01%	2831

Other funds holding MORF

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Hoey Investments Coatesville, Pennsylvania $693M AUM 34.99% 1-Year Est. Return

Lindbrook Capital's MORF Position: Q3 2024 in Review

Lindbrook Capital sold out of Morphic Holding, Inc. Common Stock (MORF) in Q3 2024, closing a stake of 122 shares — an estimated $4.16K sold.

Lindbrook Capital first reported a position in MORF in Q2 2022 and held it in 8 quarters. The position peaked at $4.16K in Q2 2024. 2 funds tracked by Wall St. Rank hold MORF as of Q3 2024.

Lindbrook Capital reported no remaining Morphic Holding, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Lindbrook Capital sold 122 Morphic Holding, Inc. Common Stock shares in Q3 2024, an estimated $4.16K.
Lindbrook Capital first reported a position in Morphic Holding, Inc. Common Stock in Q2 2022 and held it in 8 quarters.
Lindbrook Capital's Morphic Holding, Inc. Common Stock position peaked at $4.16K in Q2 2024.
2 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q3 2024.

Based on Lindbrook Capital's 13F filing for Q3 2024, filed 1 Nov 2024.